aggame¹ÙÍø

ͼƬÃû³Æ

ÐÂÎÅ×ÊѶ

ÕãÒ½¶ùÔºÍŶÓ×îÐÂÑо¿Ð§¹û£ºÊ¯É¼¼î¼×ÓÐÍûÖÎÁÆÌÇÄò²¡Éö²¡

ÈÕÆÚ£º

2024Äê10ÔÂ26ÈÕ 08:51


½üÆÚ£¬£¬£¬£¬£¬ £¬£¬£¬ÓÉÕã½­´óѧҽѧԺÁ¥Êô¶ùͯҽԺÉöÄÚ¿ÆÍŶÓÓëaggame¹ÙÍøÏàÖú¿ªÕ¹µÄʯɼ¼î¼×ÖÎÁÆÌÇÄò²¡Éö²¡µÄ¶à×éѧÆÊÎöÑо¿½ÒÏþÁË×îÐÂÑо¿Ð§¹û£¬£¬£¬£¬£¬ £¬£¬£¬Ñо¿Åú×¢Îúʯɼ¼î¼×ÔÚ¼õÇáÌÇÄò²¡ÓÕµ¼µÄÉöËðÉË¡¢Ö¬ÖÊ´úлÔÓÂÒºÍÑ×Ö¢·½ÃæÏÔʾ³öÓÐÏ£ÍûµÄÖÎÁƹ¦Ð§¡£¡£¡£¡£¡£¡£¡£¸ÃÑо¿ÒѽÒÏþÓÚ¡¶Pharmacological Research¡·ÔÓÖ¾£¬£¬£¬£¬£¬ £¬£¬£¬È«ÃûΪ“Huperzine A targets Apolipoprotein E: A potential therapeutic drug for diabetic nephropathy based on omics analysis”¡£¡£¡£¡£¡£¡£¡£

ÔçÔÚ2020Ä꣬£¬£¬£¬£¬ £¬£¬£¬Õã½­´óѧҽѧԺÁ¥Êô¶ùͯҽԺ¾ÍÓëaggame¹ÙÍøÏàÖú¿ªÕ¹¹ýÑÎËáä强ÐÂÆ¬¶Ô¶ùͯÐÂÐ͹Ú×´²¡¶¾Ñ¬È¾µÄÁÆÐ§¼°Çå¾²ÐÔÆÀ¼ÛÑо¿¡£¡£¡£¡£¡£¡£¡£ÏÖÔÚÔÙ´ÎÁªÊÖ£¬£¬£¬£¬£¬ £¬£¬£¬ÓÖÔÚÐµļ²²¡ÁìÓòÈ¡µÃÁËϲÈ˵ÄЧ¹û¡£¡£¡£¡£¡£¡£¡£

 

ʯɼ¼î¼×£º×ÔÈ»À¡ÔùµÄ¶àÃæÄÜÊÖ

ʯɼ¼î¼×(Huperzine A£¬£¬£¬£¬£¬ £¬£¬£¬Hup A)×÷ΪÑÇÖÞÖ²ÎïÉß×ãʯɼµÄÌáÈ¡ÎïÁÙ´²Ö÷ÒªÓÃÓÚÉñ¾­ÍËÐÐÐÔ²¡ÖÎÁÆ£¬£¬£¬£¬£¬ £¬£¬£¬µ«½üÄêÀ´Ñо¿·¢Ã÷ÆäÔÚÌÇÄò²¡ÊÓÍøÄ¤²¡±äÖоßÓÐÏÔÖøµÄ½µÑªÌǺͿ¹Ñ××÷Óᣡ£¡£¡£¡£¡£¡£µ«Æä¸üÆÕ±éµÄ±£» £»£»£»£»£»£»¤×÷Ó㬣¬£¬£¬£¬ £¬£¬£¬ÌØÊâÊǶÔÌÇÄò²¡ÁíÒ»²¢·¢Ö¢ÌÇÄò²¡Éö²¡Éö¹¦Ð§µÄ±£» £»£»£»£»£»£»¤×÷ÓÃÈÔδ±»Ñо¿¡£¡£¡£¡£¡£¡£¡£

 

ÌÇÄò²¡Éö²¡£¡£¡£¡£¡£¡£¡£ºÇÄȻDZÔڵĿµ½¡É±ÊÖ

ÌÇÄò²¡£¡£¡£¡£¡£¡£¡£¨DM£©×÷Ϊ³£¼û²¡¡¢¶à·¢²¡£¡£¡£¡£¡£¡£¡£¬£¬£¬£¬£¬ £¬£¬£¬ÊÇÑÏÖØÍþвÈËÀ࿵½¡µÄÌìÏÂÐÔ¹«¹²ÎÀÉúÎÊÌâ¡£¡£¡£¡£¡£¡£¡£ÏÖÔÚÔÚÌìϹæÄ£ÄÚ£¬£¬£¬£¬£¬ £¬£¬£¬ÌÇÄò²¡»¼²¡Âʺͻ¼²¡ÈËÊý¼±¾çÉÏÉý£¬£¬£¬£¬£¬ £¬£¬£¬¾Ý¹ú¼ÊÌÇÄò²¡Í¬ÃË£¨IDF£©Í³¼Æ£º2021ÄêÈ«Çò³ÉÄêÌÇÄò²¡ÈËÊýÒÑ´ï5.37ÒÚ£¬£¬£¬£¬£¬ £¬£¬£¬½Ï2019ÄêÔöÌí½ü16%£¬£¬£¬£¬£¬ £¬£¬£¬Ô¤¼Æµ½2045ÄêÈ«ÇòÌÇÄò²¡»¼²¡×ÜÈËÊý½«µÖ´ï7.83ÒÚ£» £»£»£»£»£»£»2021ÄêÈ«ÇòÒòÌÇÄò²¡éæÃüÈËÊý´ï670Íò¡£¡£¡£¡£¡£¡£¡£

½ü40¶àÄêÀ´£¬£¬£¬£¬£¬ £¬£¬£¬Ëæ×ÅÎÒ¹ú¾­¼Ã¸ßËÙÉú³¤¡¢ÉúÑÄ·½·¨Î÷·½»¯¡¢¶¼»á»¯ºÍÉú³ÝÀÏÁ仯¡¢·ÊÅÖÂÊÉÏÉý£¬£¬£¬£¬£¬ £¬£¬£¬ÎÒ¹úÌÇÄò²¡»¼²¡ÂÊÒ²³Ê¿ìËÙÔöÌíÇ÷ÊÆ£º1980ÄêÎÒ¹ú³ÉÈËÌÇÄò²¡»¼²¡ÂÊΪ0.67%£¬£¬£¬£¬£¬ £¬£¬£¬2007 Äê´ï9.7%£¬£¬£¬£¬£¬ £¬£¬£¬2017Äê¸ü¸ß´ï 11.7%¡£¡£¡£¡£¡£¡£¡£ÌÇÄò²¡Ç°ÆÚµÄ±ÈÀý¸ü¸ß¡£¡£¡£¡£¡£¡£¡£¸üΪÑÏÖØµÄÊÇÎÒ¹úÔ¼ÓÐ50%µÄÌÇÄò²¡Î´±»Õï¶Ï£» £»£»£»£»£»£»°ÕÁ˽ÓÊÜÖÎÁÆÕߣ¬£¬£¬£¬£¬ £¬£¬£¬ÌÇÄò²¡¿ØÖÆ×´Ì¬Ò²²»²ÇÏë¡£¡£¡£¡£¡£¡£¡£IDFÊý¾ÝÏÔʾ£¬£¬£¬£¬£¬ £¬£¬£¬×èÖ¹2021ÄêÎÒ¹ú³ÉÈËÌÇÄò²¡ÊýĿΪ1.41ÒÚ¡£¡£¡£¡£¡£¡£¡£ÎÒ¹úÒÑÈ»³ÉΪȫÌìÏÂÌÇÄò²¡»¼Õß×î¶àµÄ¹ú¼Ò¡£¡£¡£¡£¡£¡£¡£

¶øÌÇÄò²¡Éö²¡(diabetic nephropathy£¬£¬£¬£¬£¬ £¬£¬£¬DN)ÊÇÌÇÄò²¡×îÖ÷ÒªÇÒ×îÑÏÖØµÄ²¢·¢Ö¢Ö®Ò»£¬£¬£¬£¬£¬ £¬£¬£¬·¢²¡»úÖÆÖØ´ó£¬£¬£¬£¬£¬ £¬£¬£¬Éæ¼°Ñõ»¯Ó¦¼¤¡¢Ñ×Ö¢¡¢ÏËά»¯ºÍϸ°ûµòÍö£¬£¬£¬£¬£¬ £¬£¬£¬ÁÙ´²ÌØÕ÷ΪһÁ¬ÐÔ°×ÂѰ×ÄòÉøÍ¸ÔöÌí£¬£¬£¬£¬£¬ £¬£¬£¬ÉöСÇòÂ˹ýÂÊ£¨eGFR£©¾ÙÐÐÐÔϽµ£¬£¬£¬£¬£¬ £¬£¬£¬×îÖÕÉú³¤ÎªÖÕÄ©ÆÚÉö²¡£¡£¡£¡£¡£¡£¡£¨ESRD£©£¬£¬£¬£¬£¬ £¬£¬£¬½ìʱÉöÔ๦Ч»ù±¾Ëðʧ£¬£¬£¬£¬£¬ £¬£¬£¬ÑݱäΪÉöË¥½ß£¬£¬£¬£¬£¬ £¬£¬£¬ÌåÄÚ·ºÆð´ó×Ú¶¾ËØ»ýÖü£¬£¬£¬£¬£¬ £¬£¬£¬Ë®¡¢µç½âÖÊ¡¢Ëá¼îʧºâ£¬£¬£¬£¬£¬ £¬£¬£¬ÖÂËÀÂʸߣ¬£¬£¬£¬£¬ £¬£¬£¬Ê®·ÖΣÏÕ¡£¡£¡£¡£¡£¡£¡£

¹ØÓÚÌÇÄò²¡Éö²¡£¡£¡£¡£¡£¡£¡£¬£¬£¬£¬£¬ £¬£¬£¬ÏÖÔÚµÄÁÙ´²ÖÎÁÆÈÔÒÔÔçÆÚ¿ØÖÆÑªÌÇ¡¢ÑªÑ¹ÎªÖ÷£¬£¬£¬£¬£¬ £¬£¬£¬¾ÙÐÐÖÁÍíÆÚÔòÐèÒª½ÓÄÉ͸ÎöµÈÉöÔàÌæ»»ÁÆ·¨¾ÙÐÐÖÎÁÆ¡£¡£¡£¡£¡£¡£¡£ÉÐÎÞÓÐÓõÄÒ©Îï¸ÉÔ¤ÊֶΡ£¡£¡£¡£¡£¡£¡£

 

¶à×éѧÆÊÎö£ºÕ¹ÏÖʯɼ¼î¼×µÄ×÷ÓûúÖÆ

±¾´ÎÑо¿ÖУ¬£¬£¬£¬£¬ £¬£¬£¬Ñо¿Ö°Ô±½ÓÄÉÁËת¼×é¡¢´úл×顢΢ÉúÎï×éºÍÍøÂçÒ©ÀíѧµÈ¶à×é±ð¶àѧ¿Æ×ÛºÏÆÊÎöÒªÁ죬£¬£¬£¬£¬ £¬£¬£¬Ì½ÌÖÁËʯɼ¼î¼×¹ØÓÚÌÇÄò²¡Éö²¡µÄÖÎÁÆ×÷Óᣡ£¡£¡£¡£¡£¡£Ñо¿Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬ £¬£¬£¬Ê¯É¼¼î¼×Äܹ»Í¨¹ýµ÷¿ØApoEµÄ±í´ï£¬£¬£¬£¬£¬ £¬£¬£¬Æðµ½±£» £»£»£»£»£»£»¤ÉöÔà¡¢µ÷Àí´úл¡¢¸ÄÉÆ³¦µÀ΢ÉúÎïȺ¡¢¸ÄÉÆÑ×Ö¢µÈ×÷Óᣡ£¡£¡£¡£¡£¡£¸ÃÑо¿Ê×´ÎÌṩÁËʯɼ¼î¼×¶ÔDNÖÎÁÆ×÷ÓõÄÖ¤¾Ý£¬£¬£¬£¬£¬ £¬£¬£¬Åúעʯɼ¼î¼×¿ÉÄÜͨ¹ý°ÐÏòµ÷¿ØApoE£¬£¬£¬£¬£¬ £¬£¬£¬³ÉΪһÖÖDZÔÚµÄÔ¤·ÀºÍÖÎÁÆDNµÄÒ©Îï¡£¡£¡£¡£¡£¡£¡£ÏêϸÈçÏ£º

1.  ÉöÔà±£» £»£»£»£»£»£»¤×÷ÓãºÔÚÁÙ´²ÖУ¬£¬£¬£¬£¬ £¬£¬£¬ÄòÂѰ×ÊÇÆÀ¹ÀÉö¹¦Ð§ºÍËðÉË¡¢ÌáÐÑÉöÔ༲²¡µÄÖ÷ÒªÖ¸±ê¡£¡£¡£¡£¡£¡£¡£Ñо¿Åú×¢£¬£¬£¬£¬£¬ £¬£¬£¬ÔÚÐÛÐÔSD´óÊó¸øÒ©Ê¯É¼¼î¼×ºó£¬£¬£¬£¬£¬ £¬£¬£¬Óë±ÈÕÕµÄδʹÓÃʯɼ¼î¼×µÄDN´óÊóÏà±È£¬£¬£¬£¬£¬ £¬£¬£¬Ê¹ÓÃÁËʯɼ¼î¼×µÄDN´óÊóÄòÂѰף¨uALB£©Ë®Æ½·ºÆð½µµÍ£¬£¬£¬£¬£¬ £¬£¬£¬²¢ÇÒÆäÉöÔàÖ¸Êý£¨kidney index£©¡¢Ñª¼¡ôû£¨SCr£©¡¢ÄòËØµª£¨BUN£©Ë®Æ½½ÔÓиÄÉÆ¡£¡£¡£¡£¡£¡£¡££¨ÈçÏÂͼ£©

£¨×¢£ºNCΪÕý³£´óÊó£» £»£»£»£»£»£»DNΪ»¼DN´óÊó£» £»£»£»£»£»£»DN+Hup AΪʹÓÃÊÇʯɼ¼î¼×µÄDN´óÊ󡣡£¡£¡£¡£¡£¡££©

 

 

ÁíÍ⣬£¬£¬£¬£¬ £¬£¬£¬´óÊóÉöСÇò£¨Glomerulus£©ºÍÉöС¹Ü£¨Renal tubule£©µÄ½á¹¹ËðÉËÔÚʯɼ¼î¼×ÖÎÁÆÏÂÒ²ÓÐËù¼õÇᣬ£¬£¬£¬£¬ £¬£¬£¬Î¬³ÖÕý³£ÉöСÇòÂ˹ý¹¦Ð§Ëù±ØÐèµÄÉö²¡ÂѰף¨Nephrin£©ºÍ×ãÍ»ÂѰף¨Podocin£©µÄÂѰ×ÖÊˮƽÔÚʯɼ¼î¼×¸øÒ©ºóÒ²ÏÔÖø»ØÉý¡£¡£¡£¡£¡£¡£¡£

±ÈÕÕδÓÃÒ©µÄDN´óÊ󣬣¬£¬£¬£¬ £¬£¬£¬Ê¹ÓÃʯɼ¼î¼×ºóµÄ´óÊóÉöÔ๦Чָ±êÒÔ¼°½á¹¹ËðÉËÔÚʹÓÃʯɼ¼î¼×ºó»ù±¾¶¼ÓÐËù¸ÄÉÆ¡£¡£¡£¡£¡£¡£¡£Òò´Ë¿ÉÒԵóö£¬£¬£¬£¬£¬ £¬£¬£¬Ê¯É¼¼î¼×±£´æ×ŶÔÉöÔàµÄ±£» £»£»£»£»£»£»¤×÷Óᣡ£¡£¡£¡£¡£¡£

2.  »ùÒò±í´ïÓ°Ï죺ΪÁË̽Ë÷ʯɼ¼î¼×ÖÎÁÆDNµÄ·Ö×Ó»úÖÆ£¬£¬£¬£¬£¬ £¬£¬£¬Ñо¿¶ÔÉöÔà×éÖ¯¾ÙÐÐÁËת¼×é²âÐòºÍ²î±ð±í´ï»ùÒò(DEG)ÆÊÎö¡£¡£¡£¡£¡£¡£¡£Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬ £¬£¬£¬ÔÚDN×éÖÐÏÔÖøÉϵ÷µÄApoEºÍApoC 2ÔÚʯɼ¼î¼×ÖÎÁƺóÏÔÖø½µµÍ¡£¡£¡£¡£¡£¡£¡£

3.  ´úлÎïµ÷Àí£ºÑо¿Í¨¹ýÖ÷ÒòËØÆÊÎö£¨PCA£©ºÍÆ«×îС¶þ³ËÅбðÆÊÎö£¨PLS-DA£©À´Ñо¿ÉöÔà´úлת±ä·¢Ã÷£¬£¬£¬£¬£¬ £¬£¬£¬NC×éºÍDN×éµÄÑùÆ·¾ßÓÐÏÔ×ÅÊèÉ¢ÐÔ£¬£¬£¬£¬£¬ £¬£¬£¬¶øDN+Hup AµÄÂþÑܸü¿¿½üNC×é¡£¡£¡£¡£¡£¡£¡£ÕâÒ²¾ÍÒâζ×Å£¬£¬£¬£¬£¬ £¬£¬£¬Ê¹ÓÃÁËʯɼ¼î¼×µÄDN´óÊóµÄÉöÔà´úлÏà±ÈÓÚδÓÃÒ©µÄDN´óÊ󣬣¬£¬£¬£¬ £¬£¬£¬ÆäÉöÔà´úлԽ·¢¿¿½üÓÚÕý³£´óÊ󡣡£¡£¡£¡£¡£¡£ÕâÅúעʯɼ¼î¼×ÖÎÁÆÒ»¶¨Ë®Æ½Éϻָ´ÁËDN´óÊóµÄ´úл¡£¡£¡£¡£¡£¡£¡££¨ÈçÏÂͼ£©

 

4.  ³¦µÀ΢ÉúÎïȺ¸ÄÉÆ£ºShannonÖ¸ÊýÊÇÆÀ¹À΢ÉúÎïȺÂä¶àÑùÐÔ»ò¸»ºñ¶ÈµÄ³£ÓÃÖ¸±ê£¬£¬£¬£¬£¬ £¬£¬£¬ÊýÖµÔ½¸ßÅúעȺÂäµÄ¶àÑùÐÔÔ½¸ß£¬£¬£¬£¬£¬ £¬£¬£¬¹ÊÑо¿ÓÃÆäÀ´ÆÀ¹Àʯɼ¼î¼×¶Ô´óÊ󳦵À΢ÉúÎïȺµÄÓ°Ïì¡£¡£¡£¡£¡£¡£¡£Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬ £¬£¬£¬DN×éµÄShannon¶àÑùÐÔÖ¸Êý½µµÍ£¬£¬£¬£¬£¬ £¬£¬£¬¶øDN+Hup A×éµÄShannon¶àÑùÐÔÖ¸ÊýÔöÌí£¬£¬£¬£¬£¬ £¬£¬£¬Åúעʯɼ¼î¼×´¦Öóͷ£µ÷ÀíÁË´óÊ󳦵À΢ÉúÎïȺ¶àÑùÐÔ¡£¡£¡£¡£¡£¡£¡££¨ÈçÏÂͼ£©

 

 

 

ÁÙ´²ÒâÒ壺ApoE×÷ΪÉúÎï±ê¼ÇÎï

Ϊ̽ÌÖApoEÓëDNÏà¹ØÉúÎï±ê¼ÇÎïµÄÁÙ´²Ïà¹ØÐÔ£¬£¬£¬£¬£¬ £¬£¬£¬Ñо¿ÄÉÈëÁË428ÀýDN»¼Õß¾ÙÐнøÒ»²½ÆÊÎö¡£¡£¡£¡£¡£¡£¡£

ÌÇ»¯ÑªºìÂѰף¨HbA1c£©ÊÇѪÌÇ¿ØÖÆË®Æ½µÄÖ÷ÒªÖ¸±ê£¬£¬£¬£¬£¬ £¬£¬£¬Í¨³£ÒÔΪ£¬£¬£¬£¬£¬ £¬£¬£¬ÌÇ»¯ÑªºìÂѰ×Ũ¶È¿ÉÓÐÓõط´Ó¦ÒÑÍù8~12ÖÜÆ½¾ùѪÌÇˮƽ¡£¡£¡£¡£¡£¡£¡£Ñо¿·¢Ã÷£¬£¬£¬£¬£¬ £¬£¬£¬HbA1cÓëApoE³ÊÕýÏà¹Ø£¬£¬£¬£¬£¬ £¬£¬£¬ÌáÐÑApoEµÄ±í´ïËæHbA1cˮƽµÄÉý¸ß¶øÔöÌí¡£¡£¡£¡£¡£¡£¡£

ÔÚÉö¹¦Ð§·½Ã棬£¬£¬£¬£¬ £¬£¬£¬ÔÚ¸ßÂѰ×ÄòˮƽÏ£¬£¬£¬£¬£¬ £¬£¬£¬ApoE±í´ïÓë24 hÄòÂѰ×ˮƽ³ÊÇ¿ÕýÏà¹Ø£¬£¬£¬£¬£¬ £¬£¬£¬Åú×¢Ëæ×ÅÂѰ×ÄòˮƽµÄÉý¸ß£¬£¬£¬£¬£¬ £¬£¬£¬ApoE±í´ïÒ²Éý¸ß¡£¡£¡£¡£¡£¡£¡£

ÁíÍ⣬£¬£¬£¬£¬ £¬£¬£¬Ñо¿»¹·¢Ã÷£¬£¬£¬£¬£¬ £¬£¬£¬ApoEÓëѪÇå°×ÂѰף¨ALB£©¡¢Ö¬ÖÊÉúÎï±ê¼ÇÎï¡¢Ñ×Ö¢±ê¼ÇÎÓÈÆäÊÇCRPºÍHsCRP£©µÈ¶¼±£´æ½ÏΪÏÔÖøµÄÏà¹ØÐÔ¡£¡£¡£¡£¡£¡£¡££¨ÈçÏÂͼ£©

 

 

Ñо¿»¹¾ÙÐÐÁËApoEÇõÍÑéÖ¤£¬£¬£¬£¬£¬ £¬£¬£¬Çõͺóµ¼ÖÂÑ×Ö¢¼õÇᡢϸ°ûÕ³¸½ÔöÌíºÍϸ°û»îÐÔÉý¸ß¡£¡£¡£¡£¡£¡£¡£ÓëNC×éÏà±È£¬£¬£¬£¬£¬ £¬£¬£¬ÇõÍ×éÖÐ×ÔÊÉÌå±ê¼ÇÎïLC 3B II/LC 3B IÂѰױí´ïÏÔÖø½µµÍ£¬£¬£¬£¬£¬ £¬£¬£¬Åú×¢ÆÏÌÑÌÇÓÕµ¼¸ü¸ßµÄ×ÔÊÉˮƽ£¬£¬£¬£¬£¬ £¬£¬£¬ÇõÍApoE½µµÍ×ÔÊÉˮƽ¡£¡£¡£¡£¡£¡£¡£

 

ÍøÂçÒ©Àíѧ£ºÑé֤ʯɼ¼î¼×µÄ¶à°Ðµã×÷ÓÃ

ͨ¹ýÍøÂçÒ©ÀíѧÆÊÎö£¬£¬£¬£¬£¬ £¬£¬£¬Ñо¿Ö°Ô±½øÒ»²½ÑéÖ¤ÁËʯɼ¼î¼×¿ÉÄÜͨ¹ý°ÐÏòµ÷¿Ø¶à¸öÓëDNÏà¹ØµÄ»ùÒòºÍ´úл;¾¶À´Ê©Õ¹×÷ÓÃ, ²¢ÇÒÄܹ»Í¨¹ý¿ØÖÆÏ¸°ûµòÍö¶øÆð±£» £»£»£»£»£»£»¤×÷Óᣡ£¡£¡£¡£¡£¡£

 

½áÂÛ£ºÊ¯É¼¼î¼×µÄDZÁ¦ÓëδÀ´Ñо¿Æ«Ïò

¸ÃÑо¿Ê×´ÎÌṩÁËʯɼ¼î¼×¶ÔDNÖÎÁÆ×÷ÓõÄÖ¤¾Ý£¬£¬£¬£¬£¬ £¬£¬£¬Åúעʯɼ¼î¼×¿ÉÄÜͨ¹ý°ÐÏòµ÷¿ØApoE£¬£¬£¬£¬£¬ £¬£¬£¬³ÉΪһÖÖDZÔÚµÄÔ¤·ÀºÍÖÎÁÆDNµÄÒ©Îï¡£¡£¡£¡£¡£¡£¡£Ö»¹ÜÑо¿È¡µÃÁËÁîÈ˹ÄÎèµÄЧ¹û£¬£¬£¬£¬£¬ £¬£¬£¬µ«ÈÔÐè½øÒ»²½µÄÁÙ´²ÊÔÑéºÍ´ó¹æÄ£¶à×éѧÊý¾ÝÑéÖ¤À´ÆÀ¹Àʯɼ¼î¼×µÄÁÙ´²ÖÎÁÆÇ±ÄÜ¡£¡£¡£¡£¡£¡£¡£

ÌÇÄò²¡Éö²¡µÄÖÎÁÆÊÇÒ»¸öÖØ´óµÄÀú³Ì£¬£¬£¬£¬£¬ £¬£¬£¬µ«ÕâÏîÑо¿ÎªÎÒÃÇÌṩÁËеÄÊӽǺÍÏ£Íû¡£¡£¡£¡£¡£¡£¡£Ëæ×ÅÑо¿µÄÉîÈ룬£¬£¬£¬£¬ £¬£¬£¬ÎÒÃÇÆÚ´ýʯɼ¼î¼×Äܹ»³ÉΪÌÇÄò²¡»¼ÕßµÄи£Òô¡£¡£¡£¡£¡£¡£¡£ÈÃÎÒÃÇÒ»Æð¹Ø×¢ÕâÒ»ÁìÓòµÄ×îÐÂÏ£Íû£¬£¬£¬£¬£¬ £¬£¬£¬ÎªÌÇÄò²¡»¼Õß´øÀ´¸ü¶àµÄÏ£ÍûºÍÑ¡Ôñ¡£¡£¡£¡£¡£¡£¡£

 

 

Ñо¿ÎÄÏ×ȪԴ£º

 

 

 

ÉùÃ÷£º

1.±¾ÐÂÎÅÖ¼ÔÚ·ÖÏíѧÊõÇ°ÑØ¶¯Ì¬£¬£¬£¬£¬£¬ £¬£¬£¬½ö¹©Ò½ÁÆÎÀÉúרҵÈËÊ¿»ùÓÚѧÊõÄ¿µÄ²ÎÔÄ£¬£¬£¬£¬£¬ £¬£¬£¬·Ç¹ã¸æÓÃ;¡£¡£¡£¡£¡£¡£¡£

2.aggame¹ÙÍøÖÆÒ©²î³ØÈκÎÒ©Æ·ºÍ/»ò˳Ӧ֢×÷ÍÆ¼ö¡£¡£¡£¡£¡£¡£¡£

Ïà¹ØÍÆ¼ö

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿